WPW
DFTX

Waldron Private Wealth’s Definium Therapeutics DFTX Stock Holding History

Waldron Private Wealth’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$297K Buy
+6,321
New +$156K 0.01% 288

Other funds holding DFTX

PFA
Peak Financial Advisors Denver, Colorado $242M AUM 19.63% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
BRG
Bay Rivers Group Williamsburg, Virginia $293M AUM 48.17% 1-Year Est. Return
SCI
Stableford Capital II Scottsdale, Arizona $289M AUM 20.84% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
CSP
Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
FSBI
Fearless Solutions (Best Invest) San Antonio, Texas $189M AUM 32.69% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return

Waldron Private Wealth's DFTX Position: Q2 2026 in Review

Waldron Private Wealth opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 6,321 shares worth $297K. The stake represents 0.01% of the portfolio and ranks #288 among its holdings.

29 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Waldron Private Wealth held 6,321 shares of Definium Therapeutics worth $297K as of Q2 2026.
  • Definium Therapeutics was a new Waldron Private Wealth position in Q2 2026.
  • Definium Therapeutics made up 0.01% of Waldron Private Wealth's portfolio in Q2 2026, its #288 holding.
  • 29 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Waldron Private Wealth's 13F filing for Q2 2026, filed 20 Jul 2026.